INFUSYSTEM HOLDINGS, INC Derivative Liability
INFUSYSTEM HOLDINGS, INC (INFU) had Derivative Liability of $0 as of 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2013-11-12
- 2013-09-30: Derivative Liability $0.00.
- 2013-06-30: Derivative Liability $0.00.
- 2013-03-31: Derivative Liability $0.00.
- 2012-12-31: Derivative Liability $0.00.
| Period end | Derivative Liability |
|---|---|
| 2013-09-30 | $0.00 10-Q · filed 2013-11-12 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-13 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-13 |
| 2012-12-31 | $0.00 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |